Ats Medical — Shareholder Meeting (May 2008)
18 slides from Ats Medical's shareholder meeting presentation, May 13, 2008
Slide 1: ATS Medical
ATS MEDICAL NASDAQ Symbol: ATSI
Slide 2: Agenda
AGENDA Introductions Business Items Election of Directors Authorization of Additional Shares NASDAQ Share Issuance Limitations Stock Incentive Plan Shares Ratification of Independent Auditors Voting Past, Present, Future: ATS Medical, Inc. Questions Adjourn
Slide 3: The "Right" Vision
THE "RIGHT" VISION Focused right on cardiac surgery.
Slide 4: ATS Business Thesis
ATS BUSINESS THESIS = = Atrial Fibrillation Heart Valve Disease Aging Global Population Structural Heart Disease Worldwide Demand Superior Products Cardiac Surgeon Centered
Slide 5: Superior Product Solutions
• Superior Product Solutions Heart Valve Therapy ATS Open Pivot(r) Mechanical Valves ATS 3f(r) Tissue Valves ATS Simulus(r) Valve Repair Products Atrial Fibrillation ATS CryoMaze(tm) Surgical Ablation System ATS MEDICAL Core Competencies
Slide 6: Strategic Focus: Minimally Invasive Surgery Friendly Technology
STRATEGIC FOCUS Minimally Invasive Surgery (MIS) Friendly Technology Traditional Open-Chest MIS Approach
Slide 7: Expanding Market Opportunities
EXPANDING MARKET OPPORTUNITIES ATS Revenue Opportunity Growth rates of markets entered since 2004 Tissue Heart Valves 5-7% Surgical AFIB Ablation 20%+ Mitral Valve Repair 5-7%
Slide 8: A Global Presence
ACLA Revenue: $15M ('08 Est.) Growth: ~21% ('08 Est.) U.S. Revenue: $25M ('08 Est.) Growth: ~33% ('08 Est.) EMEA Revenue: $24M ('08 Est.) Growth: ~30% ('08 Est.) A GLOBAL PRESENCE
Slide 9: Revenue History
REVENUE HISTORY ($ Millions)
Slide 10: Steady Gross Margin Expansion
Steady Gross Margin Expansion Manufacturing efficiencies Margin accretive acquisitions and new product introductions Direct sales expansion into high margin markets GROSS MARGIN HISTORY
Slide 11: Intellectual Property
Electronic sensing, monitoring and/or pacing circuitry in heart valves Manufacturing technique Laser Method patent regarding the use of a laser to cut tissue Cut edges are melted to discourage delamination or fraying Beneficial as tissue valves move towards new and more complicated designs, especial
Slide 12: ATS Growth Strategy
Delivering Innovative Products and Services Building the Brand Value/Equity Leveraging the Infrastructure ATS GROWTH STRATEGY
Slide 13: Mechanical Valves: Improved Blood and Materials Compatibility
Forcefield Treated - -NO PLATELETS- Control Forcefield(tm) Acute Human Experience Stent Results MECHANICAL VALVES Improved Blood and Materials Compatibility
Slide 14: ATS 3f Enable Aortic Bioprosthesis
ATS 3f(r) ENABLE(tm) AORTIC BIOPROSTHESIS Sutureless Implant Procedure Video
Slide 15: Atrial Fibrillation: ATS CryoMaze Procedure
ATRIAL FIBRILLATION MIS Stand-Alone ATS CryoMaze(tm) Procedure
Slide 16: Progress Toward Profitability
PROGRESS TOWARD PROFITABILITY ($ Millions) Diversified revenue stream Continuous margin improvement Leveraged distribution infrastructure Note: EBITDA is defined as earnings adjusted to exclude interest, taxes, depreciation and amortization
Slide 17: Agenda
AGENDA Introductions Business Items Election of Directors Authorization of Additional Shares NASDAQ Share Issuance Limitations Stock Incentive Plan Shares Ratification of Independent Auditors Voting Past, Present, Future: ATS Medical, Inc. Questions Adjourn
Slide 18: Thank You!
ATS MEDICAL Thank You!